Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Stryker (SYK) through the VizualStocks API.
Net sales from Stryker's endoscopic equipment and operating-room communications systems, used to visualize and support minimally invasive procedures. Certain installation, training and ongoing-service revenue is recognized over time.
endoscopyRevenueNet sales from Stryker implants and related surgical products used in total and partial hip-replacement procedures. This is a product line within Orthopaedics, not the entire segment.
hipsRevenueNet sales from Stryker surgical equipment, patient and caregiver safety products, brain and skull-surgery products, orthobiologics and spine enabling technologies. Beginning in 2026, Neuro Cranial and enabling technologies moved into Instruments while orthopaedic power tools and cutting accessories moved to Ortho Tech.
instrumentsRevenueStryker net sales outside the United States across its MedSurg and Neurotechnology and Orthopaedics businesses. It is a geographic split of consolidated sales rather than a separate operating segment.
internationalRevenueNet sales from Stryker implants and related surgical products used in total and partial knee-replacement procedures. This is a product line within Orthopaedics, not the entire segment.
kneesRevenueNet sales from Stryker patient-handling and emergency equipment, intensive-care disposable products, clinical communications and AI-assisted virtual-care technology. The category includes both hospital equipment and connected-care products rather than a generic medical segment.
medicalRevenueOperating income from Stryker's surgical equipment, endoscopy, patient-care, vascular and neurotechnology businesses after segment cost of sales, research and development, selling and administrative expense and depreciation. Corporate costs, acquisition charges, purchased-intangible amortization and other unallocated items are excluded.
medsurgAndNeurotechnologyOperatingIncomeNet sales from Stryker's surgical equipment and safety products, endoscopy systems, patient-handling and emergency-care equipment, connected-care technology, and vascular and brain-surgery products. It is one of Stryker's two reportable segments.
medsurgAndNeurotechnologyRevenueHistorical net sales from Stryker products for traditional brain and open-skull surgery, orthobiologics, synthetic bone grafts and vertebral augmentation. Neuro Cranial stopped being a separate revenue category in 2026 when Stryker folded it into Instruments.
neuroCranialRevenueNet sales from minimally invasive products used to treat ischemic and hemorrhagic stroke and venous thromboembolism. Stryker renamed Neurovascular to Vascular in 2025 after acquiring Inari Medical and adding its peripheral vascular thrombectomy products.
neurovascularRevenueStryker's year-over-year net-sales growth after translating the current and prior periods at the same exchange rates and excluding acquisitions and divestitures. It is intended to show growth from the underlying business rather than currency or portfolio changes.
organicNetSalesGrowthOperating income from Stryker's joint-replacement, trauma, extremities, orthopaedic technology and remaining spinal-implant businesses after segment cost of sales, research and development, selling and administrative expense and depreciation. Corporate and acquisition-related costs and other unallocated items are excluded.
orthopaedicsOperatingIncomeNet sales from Stryker implants and surgical technology used in hip, knee, shoulder, ankle, trauma and extremities procedures, plus remaining spinal-implant activity. The segment also includes Mako robotic surgery, navigation, power tools and cutting accessories through Ortho Tech.
orthopaedicsRevenueNet of items Stryker does not allocate to its two segments when reconciling segment profit to consolidated operating income. It includes corporate costs, acquisition and integration charges, purchased-intangible amortization, restructuring, impairments, medical-device compliance, recalls, legal matters and other period-specific adjustments.
otherOperatingIncomeReconciliationHistorical Orthopaedics revenue outside knees, hips, trauma and extremities and spinal implants, principally Mako robotic surgery and enabling technologies. Stryker replaced this category with Ortho Tech in 2026 and added orthopaedic power tools and cutting accessories transferred from Instruments.
otherOrthopaedicsRevenueNet sales from Stryker implants used in spinal surgery after interventional-spine and enabling-technology products were moved to other categories. Revenue fell sharply after Stryker sold its U.S. Spinal Implants business in April 2025 and proceeded with sales in certain international markets.
spinalImplantsRevenueNet sales from Stryker implants and related surgical products used to repair fractures and treat shoulder, foot, ankle and other extremity conditions. It is an Orthopaedics product line rather than a measure of procedure volume.
traumaAndExtremitiesRevenueStryker net sales in the United States across its MedSurg and Neurotechnology and Orthopaedics businesses. It is a geographic split of consolidated sales rather than a separate operating segment.
unitedStatesRevenue